ArticlePLoS pathogens2024

A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system.

Francesco Costacurta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.